{{Rsnum
|rsid=1325310
|Gene=CACNA1S
|Chromosome=1
|position=201110107
|Orientation=minus
|GMAF=0.393
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=CACNA1S
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 7.1 | 39.8 | 53.1
| HCB | 39.0 | 50.0 | 11.0
| JPT | 46.0 | 40.7 | 13.3
| YRI | 9.6 | 40.4 | 50.0
| ASW | 10.5 | 40.4 | 49.1
| CHB | 39.0 | 50.0 | 11.0
| CHD | 42.2 | 44.0 | 13.8
| GIH | 13.9 | 45.5 | 40.6
| LWK | 13.6 | 43.6 | 42.7
| MEX | 24.1 | 39.7 | 36.2
| MKK | 4.6 | 39.2 | 56.2
| TSI | 4.0 | 43.6 | 52.5
| HapMapRevision=28
}}
{{omim
|desc=THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO
|id=114208
|rsnum=1325310
|variant=0006
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}